| Ident. | Authors (with country if any) | Title |
|---|
| 000106 (2017) |
Annalisa Ruggeri [France] ; Fernanda Volt [France] ; Franco Locatelli [Italie] ; Gerard Michel [France] ; Cristina Diaz De Heredia [Espagne] ; Manuel Abecasis [Portugal] ; Marco Zecca [Italie] ; Ajay Vora [Royaume-Uni] ; Karima Yakouben [France] ; Tracey A. O'Brien [Australie] ; Stefano Giardino [Italie] ; Jacqueline Cornish [Royaume-Uni] ; Vanderson Rocha [Brésil] ; Christina Peters [Autriche] ; Peter Bader [Allemagne] ; Eliane Gluckman [Monaco] ; Jean Hugues Dalle [France] | Unrelated Cord Blood Transplantation for Acute Leukemia Diagnosed in the First Year of Life: Outcomes and Risk Factor Analysis. |
| 000486 (2017) |
Mark C. Gillies [Australie] ; Vincent Daien [France] ; Vuong Nguyen [Australie] ; Daniel Barthelmes [Suisse] | Re: Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group, et al.: Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials (Ophthalmology 2016;123:1751-1761). |
| 000548 (2017) |
Parul U. Gandhi [États-Unis] ; Sheryl L. Chow [États-Unis] ; Thomas S. Rector [États-Unis] ; Henry Krum [Australie] ; Hanna K. Gaggin [États-Unis] ; John J. Mcmurray [Royaume-Uni] ; Michael R. Zile [États-Unis] ; Michel Komajda [France] ; Robert S. Mckelvie [Canada] ; Peter E. Carson [États-Unis] ; James L. Januzzi [États-Unis] ; Inder S. Anand [États-Unis] | Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction. |
| 000915 (2017) |
Peter Nash [Australie] ; Bruce Kirkham [Royaume-Uni] ; Masato Okada [Japon] ; Proton Rahman [Canada] ; Benard Combe [France] ; Gerd-Ruediger Burmester [Allemagne] ; David H. Adams [États-Unis] ; Lisa Kerr [États-Unis] ; Chin Lee [États-Unis] ; Catherine L. Shuler [États-Unis] ; Mark Genovese [États-Unis] | Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial. |
| 000930 (2017) |
Justin J. L. Wong [Australie] ; Dadi Gao [Australie] ; Trung V. Nguyen [Australie] ; Chau-To Kwok [Australie] ; Michelle Van Geldermalsen [Australie] ; Rob Middleton [Australie] ; Natalia Pinello [Australie] ; Annora Thoeng [Australie] ; Rajini Nagarajah [Australie] ; Jeff Holst [Australie] ; William Ritchie [Australie, France] ; John E. J. Rasko [Australie] | Intron retention is regulated by altered MeCP2-mediated splicing factor recruitment |
| 000A79 (2017) |
Shane Malone [Portugal] ; Adam Owen [France] ; Bruno Mendes [France] ; Brian Hughes [Irlande (pays)] ; Kieran Collins [Irlande (pays)] ; Tim J. Gabbett [Australie] | High-speed running and sprinting as an injury risk factor in soccer: Can well-developed physical qualities reduce the risk? |
| 000B22 (2017) |
Emil Hagström [Suède] ; Claes Held [Suède] ; Ralph A H. Stewart [Nouvelle-Zélande] ; Philip E. Aylward [Australie] ; Andrzej Budaj [Pologne] ; Christopher P. Cannon [États-Unis] ; Wolfgang Koenig [Allemagne] ; Sue Krug-Gourley [États-Unis] ; Emile R. Mohler [États-Unis] ; Philippe Gabriel Steg [France] ; Elizabeth Tarka [États-Unis] ; Ollie Östlund [Suède] ; Harvey D. White [Nouvelle-Zélande] ; Agneta Siegbahn [Suède] ; Lars Wallentin [Suède] | Growth Differentiation Factor 15 Predicts All-Cause Morbidity and Mortality in Stable Coronary Heart Disease. |
| 000D70 (2017) |
Nour Baïz [France] ; Patricia Macchiaverni [Brésil] ; Meri K. Tulic [Australie] ; Akila Rekima [France] ; Isabella Annesi-Maesano [France] ; Valérie Verhasselt [Australie] | Early oral exposure to house dust mite allergen through breast milk: A potential risk factor for allergic sensitization and respiratory allergies in children. |
| 001221 (2017) |
Ray K. Boyapati [Royaume-Uni, Australie] ; Arina Tamborska [Royaume-Uni] ; David A. Dorward [Royaume-Uni] ; Gwo-Tzer Ho [Royaume-Uni] | Advances in the understanding of mitochondrial DNA as a pathogenic factor in inflammatory diseases |
| 001266 (2017) |
Zhanna Shekhovtsova [France, Russie] ; Carmem Bonfim [Brésil] ; Annalisa Ruggeri [France] ; Samantha Nichele [Brésil] ; Kristin Page [États-Unis] ; Amal Alseraihy [Arabie saoudite] ; Francisco Barriga [Chili] ; José Sánchez De Toledo Codina [Espagne] ; Paul Veys [Royaume-Uni] ; Jaap Jan Boelens [Pays-Bas] ; Karin Mellgren [Suède] ; Henrique Bittencourt [Canada] ; Tracey O Rien [Australie] ; Peter J. Shaw [Australie] ; Alicja Chybicka [Pologne] ; Fernanda Volt [France] ; Federica Giannotti [France] ; Eliane Gluckman [France, Monaco] ; Joanne Kurtzberg [États-Unis] ; Andrew R. Gennery [Royaume-Uni] ; Vanderson Rocha [France, Royaume-Uni] | A risk factor analysis of outcomes after unrelated cord blood transplantation for children with Wiskott-Aldrich syndrome |
| 001507 (2016) |
Charlotte Viant [France] ; Lucille C. Rankin [Australie] ; Mathilde J H. Girard-Madoux [France] ; Cyril Seillet [Australie] ; Wei Shi [Australie] ; Mark J. Smyth [Australie] ; Laurent Bartholin [France] ; Thierry Walzer [France] ; Nicholas D. Huntington [Australie] ; Eric Vivier [France] ; Gabrielle T. Belz [Australie] | Transforming growth factor-β and Notch ligands act as opposing environmental cues in regulating the plasticity of type 3 innate lymphoid cells. |
| 001531 (2016) |
Morgane Bourcy [Belgique] ; Meggy Suarez-Carmona [Belgique] ; Justine Lambert [Belgique] ; Marie-Emilie Francart [Belgique] ; Hélène Schroeder [Belgique] ; Céline Delierneux [Belgique] ; Nicolas Skrypek [Belgique] ; Erik W. Thompson [Australie] ; Guy Jérusalem [Belgique] ; Geert Berx [Belgique] ; Marc Thiry [Belgique] ; Silvia Blacher [Belgique] ; Brett G. Hollier [Australie] ; Agnès Noël [Belgique] ; Cécile Oury [Belgique] ; Myriam Polette [France] ; Christine Gilles [Belgique] | Tissue Factor Induced by Epithelial-Mesenchymal Transition Triggers a Procoagulant State That Drives Metastasis of Circulating Tumor Cells. |
| 001669 (2016) |
B. Bailly [Australie] ; C.-A. Richard [France] ; G. Sharma [Singapour] ; L. Wang ; L. Johansen [États-Unis] ; J. Cao ; V. Pendharkar [Singapour] ; D.-C. Sharma [Singapour] ; M. Galloux [France] ; Y. Wang ; R. Cui ; G. Zou ; P. Guillon [Australie] ; M. Von Itzstein [Australie] ; J.-F. Eléouët [France] ; R. Altmeyer [Australie, Singapour, États-Unis] | Targeting human respiratory syncytial virus transcription anti-termination factor M2-1 to inhibit in vivo viral replication |
| 001685 (2016) |
Frédéric Sergent ; Pascale Hoffmann ; Sophie Brouillet ; Vanessa Garnier ; Aude Salomon ; Padma Murthi ; Mohamed Benharouga ; Jean-Jacques Feige ; Nadia Alfaidy | Sustained Endocrine Gland-Derived Vascular Endothelial Growth Factor Levels Beyond the First Trimester of Pregnancy Display Phenotypic and Functional Changes Associated With the Pathogenesis of Pregnancy-Induced Hypertension. |
| 001917 (2016) |
J. Yang [Australie] ; B. Faverjon [Australie] ; D. Dureisseix [France] ; P. Swider [France] ; N. Kessissoglou [Australie] | Prediction of the intramembranous tissue formation during perisprosthetic healing with uncertainties. Part 1. Effect of the variability of each biochemical factor. |
| 001935 (2016) |
Kevin D. Shield [France] ; D. Maxwell Parkin [Royaume-Uni] ; David C. Whiteman [Australie] ; Jürgen Rehm [Canada] ; Vivian Viallon [France] ; Claire Marant Micallef [France] ; Paolo Vineis [Italie, Royaume-Uni] ; Lesley Rushton [Royaume-Uni] ; Freddie Bray [France] ; Isabelle Soerjomataram [France] | Population Attributable and Preventable Fractions: Cancer Risk Factor Surveillance, and Cancer Policy Projection |
| 001B85 (2016) |
Gili Kenet [Israël] ; Hervé Chambost [France] ; Christoph Male [Autriche] ; Thierry Lambert [France] ; Susan Halimeh [Allemagne] ; Tatiana Chernova [Russie] ; Maria Elisa Mancuso [Italie] ; Julie Curtin [Australie] ; Christine Voigt [États-Unis] ; Yanyan Li [États-Unis] ; Iris Jacobs [États-Unis] ; Elena Santagostino [Italie] | Long-Acting Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Children |
| 001F69 (2016) |
Evelyn Despierre [Belgique] ; Ignace Vergote [Belgique] ; Ryan Anderson [États-Unis] ; Corneel Coens [Belgique] ; Dionyssios Katsaros [Italie] ; Fred R. Hirsch [États-Unis] ; Bram Boeckx [Belgique] ; Marileila Varella-Garcia [États-Unis] ; Annamaria Ferrero [Italie] ; Isabelle Ray-Coquard [France] ; John A. Green [Royaume-Uni] ; Christopher Steer [Australie] ; Els M J J. Berns [Pays-Bas] ; Antonio Casado [Espagne] ; Diether Lambrechts [Belgique] ; Antonio Jimeno [États-Unis] | Erratum to: Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy. |
| 002025 (2016) |
Sherene Loi [Australie] ; Urania Dafni [Grèce] ; Dimitris Karlis [Grèce] ; Varvara Polydoropoulou [Grèce] ; Brandon M. Young [États-Unis] ; Scooter Willis [États-Unis] ; Bradley Long [États-Unis] ; Evandro De Azambuja [Belgique] ; Christos Sotiriou [Belgique] ; Giuseppe Viale [Italie] ; Josef Rüschoff [Allemagne] ; Martine J. Piccart [Belgique] ; Mitch Dowsett [Royaume-Uni] ; Stefan Michiels [France] ; Brian Leyland-Jones [États-Unis] | Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab: A Secondary Analysis of the HERA Trial. |
| 002030 (2016) |
Fabien Bernard Vincent [Australie] ; Stephan Pavy [France] ; Roman Krzysiek [France] ; Thierry Lequerré [France] ; Jérémie Sellam [France] ; Yassine Taoufik [France] ; Xavier Mariette [France] ; Corinne Miceli-Richard [France] | Effect of serum anti-tumour necrosis factor (TNF) drug trough concentrations and antidrug antibodies (ADAb) to further anti-TNF short-term effectiveness after switching in rheumatoid arthritis and axial spondyloarthritis. |
| 002060 (2016) |
Angela C. Baird ; Dominic Mallon ; Graham Radford-Smith ; Julien Boyer ; Thierry Piche ; Susan L. Prescott ; Ian C. Lawrance ; Meri K. Tulic | Dysregulation of innate immunity in ulcerative colitis patients who fail anti-tumor necrosis factor therapy |
